DIRS.INFO The most relevant business & tech news

☆ Mike Johnson, the new House speaker, is well within the mainstream of today’s GOP
▼ + stars: | 2023-10-28 | by ( Harry Enten | ) edition.cnn.com time to read: +5 min

CNN —Republicans’ long public nightmare came to an end this past week when Louisiana’s Mike Johnson became the 56th speaker of the House. Their votes were outside the mainstream among all House members but not within the House Republican Conference. In other words, 37% of House Republicans are more conservative than the new speaker. That puts Johnson right in the middle third of today’s House Republican Conference. Unlike Johnson, Jordan really is out of the mainstream not just within Congress overall but the House Republican Conference, as well.

Persons: Louisiana’s Mike Johnson, Johnson, Donald Trump, Joe Biden, Biden, Biden’s, Trump, Roe, Wade, Jim Jordan, Jordan, Hal Rogers, He’s Organizations: CNN, Republicans ’, Google, Republican Party, ABC News, Washington Post, Republicans, House Republicans, House Republican Conference, Biden, Republican, Gallup, GOP, today’s House Republican Conference, yesteryear, Kentucky Rep, CBS Locations: Southern, The Ohio

☆ Opinion | The G.O.P. Goes Full-on Extremist
▼ + stars: | 2023-10-26 | by ( Paul Krugman | ) www.nytimes.com time to read: +1 min

Oh, no doubt some members are privately appalled by the views of Mike Johnson, the new speaker. What matters is what they do — and every single one of them went along with the selection of a radical extremist. There has also been considerable coverage of Johnson’s right-wing social views, but I’m not sure how many people grasp the depth of his intolerance. Johnson isn’t just someone who wants to legalize discrimination against L.G.B.T.Q. But Johnson’s extremism, and that of the party that chose him, goes beyond rejecting democracy and trying to turn back the clock on decades of social progress.

Persons: Mike Johnson, Johnson, I’m, Johnson isn’t, he’s Organizations: Republicans, L.G.B.T.Q

WASHINGTON (AP) — A low-key lawmaker in Congress for less than a decade, new House Speaker Mike Johnson isn’t recognizable to most Americans. But the social conservative and devoted ally of former President Donald Trump has been a quiet force within the Republican conference he now unexpectedly leads. “A friend to all and an enemy to none,” Republican conference chairwoman Elise Stefanik said when nominating Johnson ahead of the speaker vote Wednesday. A constitutional lawyer and former member of the Louisiana state House, Johnson was first elected to the U.S. House in 2016. Among the more conservative members of the GOP conference, Johnson has consistently opposed a woman’s right to abortion — “we will get the number of abortions to ZERO!

Persons: Mike Johnson, Donald Trump, Kevin McCarthy, “, Elise Stefanik, Johnson, ” Johnson, Newt Gingrich, —, Trump’s, Jim Jordan, Trump, ”, Doug Collins, Collins, Mike, ” Collins, Biden, Virginia Foxx, Hakeem Jeffries, Matt Gaetz, McCarthy’s, I’ve, ” Gaetz, ” McCarthy, Mario Diaz Balart, Jordan’s, Thomas Massie, Kevin Freking, Stephen Groves, Lisa Mascaro, Farnoush Amiri, Jill Colvin, Matthew Daly Organizations: WASHINGTON, Republican, Louisiana Republican, GOP, U.S . House, Twitter, Committee, Trump, ” Former Georgia, Capitol, North Carolina Rep, Democratic, Florida, Associated Press Locations: Louisiana, Israel, Georgia

☆ Johnson & Johnson Isn’t Rushing Into M&A
▼ + stars: | 2022-10-18 | by ( David Wainer | ) www.wsj.com time to read: 1 min

Most big pharma companies are moving with urgency to make acquisitions these days. The industry is sitting on a pile of cash from Covid-19 products, and many top companies need to replenish their pipelines as blockbuster drugs face generic competition this decade. Johnson & Johnson which on Tuesday reported third-quarter profit that beat analyst expectations while cutting its full-year sales guidance range, is no exception. Top-selling immunology drug Stelara, which has brought in over $7 billion in the first nine months of the year, is set to lose patent protection next year. And, like other big pharma companies, J&J is also extremely cash-rich, with about $34 billion on hand.

Search resuls for: "Johnson isn’t"

4 mentions found